Log in
Enquire now
‌

US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10040790
Patent Inventor Names
Liang Lu0
Yaping Sun0
Chunhong He0
Fenglei Zhang0
Wenqing Yao0
Date of Patent
August 7, 2018
Patent Application Number
15358371
Date Filed
November 22, 2016
Patent Citations Received
‌
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same
‌
US Patent 11407750 Derivatives of an FGFR inhibitor
0
‌
US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors
0
‌
US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors
0
‌
US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 12024517 Salts of an FGFR inhibitor
0
‌
US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
0
...
Patent Primary Examiner
‌
Susanna Moore
Patent abstract

The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.